303 related articles for article (PubMed ID: 20543579)
1. DNA methylation in endometrial cancer.
Tao MH; Freudenheim JL
Epigenetics; 2010 Aug; 5(6):491-8. PubMed ID: 20543579
[TBL] [Abstract][Full Text] [Related]
2. Epigenetics in endometrial carcinogenesis - part 1: DNA methylation.
Bartosch C; Lopes JM; Jerónimo C
Epigenomics; 2017 May; 9(5):737-755. PubMed ID: 28470096
[TBL] [Abstract][Full Text] [Related]
3. Research Progress of DNA Methylation in Endometrial Cancer.
Xu T; Ding H; Chen J; Lei J; Zhao M; Ji B; Chen Y; Qin S; Gao Q
Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883495
[TBL] [Abstract][Full Text] [Related]
4. Relationship of the aberrant DNA hypermethylation of cancer-related genes with carcinogenesis of endometrial cancer.
Banno K; Yanokura M; Susumu N; Kawaguchi M; Hirao N; Hirasawa A; Tsukazaki K; Aoki D
Oncol Rep; 2006 Dec; 16(6):1189-96. PubMed ID: 17089036
[TBL] [Abstract][Full Text] [Related]
5. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.
Fiolka R; Zubor P; Janusicova V; Visnovsky J; Mendelova A; Kajo K; Lasabova Z; Plank L; Danko J
Oncol Rep; 2013 Dec; 30(6):2878-86. PubMed ID: 24068440
[TBL] [Abstract][Full Text] [Related]
6. Quantitative DNA methylation analysis of selected genes in endometrial carcinogenesis.
Chen YC; Tsao CM; Kuo CC; Yu MH; Lin YW; Yang CY; Li HJ; Yan MD; Wang TJ; Chou YC; Su HY
Taiwan J Obstet Gynecol; 2015 Oct; 54(5):572-9. PubMed ID: 26522113
[TBL] [Abstract][Full Text] [Related]
7. Hypermethylation in promoter region of E-cadherin gene is associated with tumor dedifferention and myometrial invasion in endometrial carcinoma.
Saito T; Nishimura M; Yamasaki H; Kudo R
Cancer; 2003 Feb; 97(4):1002-9. PubMed ID: 12569599
[TBL] [Abstract][Full Text] [Related]
8. Significance of PTEN alterations in endometrial carcinoma: a population-based study of mutations, promoter methylation and PTEN protein expression.
Salvesen HB; Stefansson I; Kretzschmar EI; Gruber P; MacDonald ND; Ryan A; Jacobs IJ; Akslen LA; Das S
Int J Oncol; 2004 Dec; 25(6):1615-23. PubMed ID: 15547698
[TBL] [Abstract][Full Text] [Related]
9. New molecular aspects of endometrial carcinoma.
Nachajova M; Mersakova S; Sivakova J; Krivus S; Szepe P; Hatok J; Adamkov M
Neuro Endocrinol Lett; 2015 Dec; 36(7):638-43. PubMed ID: 26859584
[TBL] [Abstract][Full Text] [Related]
10. Promoter hypermethylation and expression of sprouty 2 in endometrial carcinoma.
Velasco A; Pallares J; Santacana M; Gatius S; Fernandez M; Domingo M; Valls J; Yeramian A; Encinas M; Dolcet X; Matias-Guiu X
Hum Pathol; 2011 Feb; 42(2):185-93. PubMed ID: 21111454
[TBL] [Abstract][Full Text] [Related]
11. Application of DNA methylation biomarkers for endometrial cancer management.
Jiang SW; Li J; Podratz K; Dowdy S
Expert Rev Mol Diagn; 2008 Sep; 8(5):607-16. PubMed ID: 18785809
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of E-cadherin expression and CDH1 promoter methylation in patients with endometrial carcinoma.
Yi TZ; Guo J; Zhou L; Chen X; Mi RR; Qu QX; Zheng JH; Zhai L
Cancer Invest; 2011 Jan; 29(1):86-92. PubMed ID: 20874004
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide DNA methylation profile of early-onset endometrial cancer: its correlation with genetic aberrations and comparison with late-onset endometrial cancer.
Makabe T; Arai E; Hirano T; Ito N; Fukamachi Y; Takahashi Y; Hirasawa A; Yamagami W; Susumu N; Aoki D; Kanai Y
Carcinogenesis; 2019 Jul; 40(5):611-623. PubMed ID: 30850842
[TBL] [Abstract][Full Text] [Related]
14. Methylation of tumor suppressor gene CDH13 and SHP1 promoters and their epigenetic regulation by the UHRF1/PRMT5 complex in endometrial carcinoma.
Sheng Y; Wang H; Liu D; Zhang C; Deng Y; Yang F; Zhang T; Zhang C
Gynecol Oncol; 2016 Jan; 140(1):145-51. PubMed ID: 26597461
[TBL] [Abstract][Full Text] [Related]
15. Promoter hypermethylation as an epigenetic component in Type I and Type II endometrial cancers.
Risinger JI; Maxwell GL; Berchuck A; Barrett JC
Ann N Y Acad Sci; 2003 Mar; 983():208-12. PubMed ID: 12724225
[TBL] [Abstract][Full Text] [Related]
16. Multiple promoters of catechol-O-methyltransferase gene are selectively inactivated by CpG hypermethylation in endometrial cancer.
Sasaki M; Kaneuchi M; Sakuragi N; Dahiya R
Cancer Res; 2003 Jun; 63(12):3101-6. PubMed ID: 12810635
[TBL] [Abstract][Full Text] [Related]
17. The Relationship between the Methylation of Promoter Regions of Tumor Suppressor Genes PTEN and APC with Endometrial Cancer.
Ghazanfari T; Asaadi Tehrani G; Maziri P
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2259-2265. PubMed ID: 31450893
[TBL] [Abstract][Full Text] [Related]
18. Absence of MGMT promoter methylation in endometrial cancer.
Rimel BJ; Huettner P; Powell MA; Mutch DG; Goodfellow PJ
Gynecol Oncol; 2009 Jan; 112(1):224-8. PubMed ID: 18973931
[TBL] [Abstract][Full Text] [Related]
19. [Pseudogene PTENP1 5'-region methylation in endometrial cancer and hyperplasias].
Kovalenko TF; Sorokina AV; Ozolinia LA; Patrushev LI
Bioorg Khim; 2013; 39(4):445-53. PubMed ID: 24707726
[TBL] [Abstract][Full Text] [Related]
20. Lynch syndrome-associated endometrial carcinoma with MLH1 germline mutation and MLH1 promoter hypermethylation: a case report and literature review.
Yokoyama T; Takehara K; Sugimoto N; Kaneko K; Fujimoto E; Okazawa-Sakai M; Okame S; Shiroyama Y; Yokoyama T; Teramoto N; Ohsumi S; Saito S; Imai K; Sugano K
BMC Cancer; 2018 May; 18(1):576. PubMed ID: 29783979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
